仁济肿瘤研究所取得肝癌研究新发现 - 2021年06月25日

Shanghai scientists said genetic screening may unlock the mystery behind why some instances of liver cancer are drug resistant and help find new targets for medication.
The article titled "Exploring liver cancer biology through functional genetic screens" by scientists from the Shanghai Cancer Research Institute under Renji Hospital was published by leading journal Nature Reviews Gastroenterology & Hepatology, the hospital announced today, claiming the article offers new insights and theories on the bottleneck of liver cancer research and guides the development of new therapeutic strategies.
As the fourth leading cause of cancer-related deaths in the world, liver cancer poses a major threat to human health. Globally, there are more than 840,000 new cases and 780,000 deaths every year, and about half of the new cases are in China.